Edap Tms Sa Revenue Growth Rates (EDAP), Current and Historic Growth - CSIMarket
CSIMarket
 


Edap Tms Sa  (NASDAQ: EDAP)
 

EDAP's Revenue Growth by Quarter and Year

Edap Tms Sa's Revenue results by quarter and year




EDAP Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 13.20
1st Quarter March 17.81
FY 31.01

EDAPs Annual Revenue
Edap Tms Sa's Revenue in the fiscal year 2025 $ 70.53 millions
Edap Tms Sa's Revenue in the fiscal year 2024 $ 69.40 millions
Edap Tms Sa's Revenue in the fiscal year 2023 $ 67.67 millions
Edap Tms Sa's Revenue in the fiscal year 2022 $ 61.72 millions
Edap Tms Sa's Revenue in the fiscal year 2021 $ 49.35 millions




EDAP Revenue second quarter 2026 Y/Y Growth Comment
Edap Tms Sa reported decrease in Revenue in the second quarter 2026 by -7.48% to $ 13.20 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Edap Tms Sa's Revenue compares unfavorably to the Company's average Revenue rise of 23.15%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 163 other companies have achieved higher Revenue growth. While Edap Tms Sa' s Revenue decline of -7.48% ranks overall at the positon no. 3463 in the second quarter 2026.




EDAP Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June -7.48 % - - -
1st Quarter March -75.2 % 6.12 % 9.64 % 25.07 %
FY   - 145.49 % 9.64 % -

Financial Statements
Edap Tms Sa's second quarter 2026 Revenue $ 13.20 millions EDAP's Income Statement
Edap Tms Sa's second quarter 2025 Revenue $ 14.27 millions Quarterly EDAP's Income Statement


EDAP Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 641.64 % - -
3rd Quarter September - -33.36 % - -
2nd Quarter June -25.87 % -80.13 % - -
1st Quarter March -74.75 % - - -
FY (Year on Year)   - 145.49 % 9.64 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #164
Healthcare Sector #472
Overall #3463

Revenue Y/Y Growth Statistics
High Average Low
111.2 % 23.15 % -7.24 %
(Dec 31 2017)   (Dec 31 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #164
Healthcare Sector #472
Overall #3463
Revenue Y/Y Growth Statistics
High Average Low
111.2 % 23.15 % -7.24 %
(Dec 31 2017)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Edap Tms Sa's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
-25.88 % -87.61 % -100 %
(Jun 30 2026)  


EDAP's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Edap Tms Sa disclosed fall in Revenue from the first quarter by -25.87% to $ 13.20 millions, from $ 17.81 millions achived in the previous reporting period.

But that's not important problem, as Edap Tms Sa's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 155 other companies have achieved higher Revenue quarter on quarter growth. While Edap Tms Sa's Revenue growth quarter on quarter, overall rank is 3368.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #467
Overall #3368
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #467
Overall #3368
Revenue Q/Q Growth Statistics
High Average Low
-25.88 % -87.61 % -100 %
(Jun 30 2026)  


EDAP's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Edap Tms Sa disclosed fall in Revenue from the first quarter by -25.87% to $ 13.20 millions, from $ 17.81 millions achived in the previous reporting period.

But that's not important problem, as Edap Tms Sa's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 155 other companies have achieved higher Revenue quarter on quarter growth. While Edap Tms Sa's Revenue growth quarter on quarter, overall rank is 3368.


Edap Tms Sa's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 111.05 $ 112.12 $ 166.11 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -0.95 % -32.51 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3463 # 1711 # 485 # 519 # 0


Cumulative Revenue growth Comment


Edap Tms Sa achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 164
Sector # 472
S&P 500 # 3463
Cumulative Revenue growth Comment


Edap Tms Sa achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 164
Sector # 472
S&P 500 # 3463




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EDAP's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Edap Tms Sa Revenue Growth Rates (EDAP), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Edap Tms Sa (CIK 1041934).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-097063
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Edap Tms Sa’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.